EP 0663839 A1 19950726 - IBUPROFEN-H 2? ANTAGONIST COMBINATIONS.
Title (en)
IBUPROFEN-H 2? ANTAGONIST COMBINATIONS.
Title (de)
KOMBINATIONEN VON IBUPROFEN MIT EINEM H2-ANTAGONISTEN.
Title (fr)
COMBINAISONS D'IBUPROFENE-ANTIHISTAMINIQUE ANTI-H 2?.
Publication
Application
Priority
- US 9308947 W 19930921
- US 95344092 A 19920929
Abstract (en)
[origin: WO9407541A1] This invention relates to pharmaceutical compositions for use in the treatment of pain and inflammation and in the relief of indigestion, sour stomach, heartburn and other gastrointestinal disorders in mammals, including humans, by administering compositions comprising (i) an analgesically and anti-inflammatory effective amount of a salt of (S)-ibuprofen substantially free of (R)-ibuprofen wherein the salt is selected from (S)-ibuprofen-(S)-lysine and (S)-ibuprofen-(R)-lysine; and (ii) an amount effective in the relief of indigestion, sour stomach, heartburn, overindulgence and other gastrointestinal disorders of at least one of the H2 antagonists.
IPC 1-7
A61K 49/00; A61K 31/445; A61K 31/425; A61K 31/415; A61K 31/34
IPC 8 full level
A61K 31/19 (2006.01); A61K 31/34 (2006.01); A61K 31/415 (2006.01); A61K 31/425 (2006.01); A61K 31/445 (2006.01); A61P 25/04 (2006.01); A61P 29/00 (2006.01)
CPC (source: EP)
A61K 31/34 (2013.01); A61K 31/415 (2013.01); A61K 31/425 (2013.01); A61K 31/445 (2013.01); A61P 25/04 (2017.12); A61P 29/00 (2017.12)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9407541 A1 19940414; AU 4931693 A 19940426; CA 2144155 A1 19940414; EP 0663839 A1 19950726; EP 0663839 A4 19980603; JP H08502254 A 19960312; MX 9306006 A 19950131
DOCDB simple family (application)
US 9308947 W 19930921; AU 4931693 A 19930921; CA 2144155 A 19930921; EP 93921709 A 19930921; JP 50913894 A 19930921; MX 9306006 A 19930928